AQR Capital Management LLC Makes New $14.83 Million Investment in Grail, Inc. (NASDAQ:GRAL)

AQR Capital Management LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 830,723 shares of the company's stock, valued at approximately $14,828,000. AQR Capital Management LLC owned approximately 2.47% of Grail at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Northern Trust Corp acquired a new position in Grail in the 4th quarter valued at $2,605,000. Tudor Investment Corp ET AL purchased a new stake in Grail in the 4th quarter valued at about $3,770,000. Public Employees Retirement Association of Colorado purchased a new position in shares of Grail during the 4th quarter worth about $50,000. Decheng Capital LLC acquired a new stake in shares of Grail in the fourth quarter worth approximately $173,000. Finally, Price T Rowe Associates Inc. MD purchased a new stake in Grail in the fourth quarter valued at approximately $438,000.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Morgan Stanley lifted their price target on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a report on Tuesday, March 18th. Canaccord Genuity Group initiated coverage on shares of Grail in a research report on Monday, April 21st. They set a "buy" rating and a $32.00 target price for the company.

Insider Buying and Selling

In related news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the transaction, the chief financial officer now owns 335,170 shares in the company, valued at $10,457,304. This trade represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 194,948 shares of company stock valued at $6,583,130 in the last quarter.

Grail Price Performance

Shares of NASDAQ GRAL traded down $0.90 on Friday, hitting $35.20. The company had a trading volume of 878,412 shares, compared to its average volume of 1,223,598. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The business has a 50 day moving average of $29.67 and a two-hundred day moving average of $25.56.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. On average, equities analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.